---
title: "Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) — Share Price, Financials & Analysis"
symbol: "BIOFILCHEM"
company: "Biofil Chemicals & Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/BIOFILCHEM"
isin: "INE829A01014"
nse_symbol: "BIOFILCHEM"
bse_code: "524396"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 57.32
generated_at: "2026-09-13T19:22:21.762Z"
---

# Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Canonical page: https://tapetide.com/stocks/BIOFILCHEM

## Company

- **NSE Symbol:** BIOFILCHEM
- **BSE Code:** 524396
- **ISIN:** INE829A01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1996-06-12
- **CEO:** Mr. Ketan Shah
- **Employees:** 26
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** biofilgroup.net

## About

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]

## Latest Price

- **Price:** ₹34.51
- **Change:** -2.28 (-6.2%)
- **Open:** ₹37.8
- **Day High:** ₹37.8
- **Day Low:** ₹32.36
- **Previous Close:** ₹36.79
- **Volume:** 173376
- **As Of:** 2026-09-11T10:25:23+00:00

## Key Fundamentals

Observed at 2026-09-11T04:53:17.794710Z.

- **Market Cap:** ₹57.32 Cr
- **Classification:** Microcap
- **P/E (reported):** 122.8
- **P/E (TTM):** 115.03
- **EPS (TTM):** ₹0.3
- **Book Value:** ₹13.25
- **Price to Book:** 2.78
- **Dividend Yield:** 0%
- **ROE:** 12.92%
- **ROCE:** 15.61%
- **Debt to Equity:** 0.14
- **Revenue (yearly):** ₹31.5 Cr
- **Net Income:** ₹2.8 Cr
- **EBITDA:** ₹3.7 Cr
- **52-Week High:** ₹46.34
- **52-Week Low:** ₹25.6
- **RSI (14):** 73.9

## Tapetide Score

- **Score:** 42 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Flat
- **Percentile:** 19.7 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 47.35 | 9% |
| growth | 50 | 9% |
| momentum | 54.54 | 12% |
| ownership | 50 | 24% |
| quality | 41.39 | 22% |
| valuation | 25.18 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Stock is trading at 2.60 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -4.50% over past five years.
- Company has a low return on equity of 1.24% over last 3 years.
- Earnings include an other income of Rs.0.31 Cr.
- Company has high debtors of 355 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 68.75% | -125.1% | -172.73% |
| ebitda margin growth | -60% | 246.78% | 268.32% | 80.24% |
| net income growth | -50% | 366.67% | 300% | 300% |
| revenue growth | 61.04% | -6.53% | -2% | -5% |
| roce | — | 286.39% | 219.22% | 7.08% |
| roe | — | 335.02% | 6.6% | 211.33% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 17.37 | 5.03 | 15.2 | 8.44 | 2.41 | 14.2 | 8.35 | 6.43 | 13.54 | 0.86 | 7.57 | 12.35 |
| Expenses | 17.13 | 4.84 | 15.24 | 8.13 | 2.29 | 13.89 | 8.24 | 6.42 | 13.42 | 0.77 | 7.14 | 12.21 |
| Operating Profit | 0.24 | 0.19 | -0.04 | 0.31 | 0.12 | 0.31 | 0.11 | 0.01 | 0.12 | 0.09 | 0.43 | 0.14 |
| OPM % | 1.38 | 3.78 | -0.26 | 3.67 | 4.98 | 2.18 | 1.32 | 0.16 | 0.89 | 10.47 | 5.68 | 1.13 |
| Other Income | 0.03 | 0.03 | 0.41 | 0.03 | 0.02 | 0.02 | 0.24 | 2.83 | 0.06 | 0.08 | 0.11 | 0.06 |
| Interest | 0.01 | 0 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
| Depreciation | 0.11 | 0.11 | 0.08 | 0.1 | 0.1 | 0.1 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Profit before tax | 0.15 | 0.11 | 0.27 | 0.23 | 0.03 | 0.22 | 0.26 | 2.76 | 0.11 | 0.1 | 0.47 | 0.13 |
| Tax % | 20 | 18.18 | 11.11 | 26.09 | 33.33 | 27.27 | 23.08 | 12.68 | 27.27 | 30 | 55.32 | 23.08 |
| Net Profit | 0.12 | 0.09 | 0.25 | 0.17 | 0.02 | 0.16 | 0.2 | 2.41 | 0.08 | 0.08 | 0.21 | 0.11 |
| EPS in Rs | 0.07 | 0.06 | 0.15 | 0.1 | 0.01 | 0.1 | 0.12 | 1.48 | 0.05 | 0.05 | 0.13 | 0.07 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 12.36 | 23.13 | 29.69 | 35.75 | 22.38 | 30.04 | 40.04 | 33.4 | 28.4 | 34.32 |
| Expenses | 11.43 | 22.11 | 27.87 | 34.15 | 21.05 | 28.88 | 39.23 | 32.55 | 27.75 | 33.54 |
| Operating Profit | 0.93 | 1.02 | 1.82 | 1.6 | 1.33 | 1.16 | 0.81 | 0.85 | 0.65 | 0.78 |
| OPM % | 7.52 | 4.41 | 6.13 | 4.48 | 5.94 | 3.86 | 2.02 | 2.54 | 2.29 | 2.27 |
| Other Income | 0.1 | 0.1 | 0.17 | 0.8 | 0.15 | 0.1 | 0.49 | 0.31 | 3.08 | 0.31 |
| Interest | 0.15 | 0.16 | 0.12 | 0.07 | 0.04 | 0.04 | 0.04 | 0.04 | 0.01 | 0 |
| Depreciation | 0.3 | 0.37 | 0.41 | 0.41 | 0.43 | 0.43 | 0.4 | 0.38 | 0.27 | 0.28 |
| Profit before tax | 0.58 | 0.59 | 1.46 | 1.92 | 1.01 | 0.79 | 0.86 | 0.74 | 3.45 | 0.81 |
| Tax % | 20.69 | 20.34 | 17.81 | 34.9 | 31.68 | 29.11 | 17.44 | 24.32 | 19.13 | — |
| Net Profit | 0.47 | 0.48 | 1.21 | 1.24 | 0.7 | 0.56 | 0.71 | 0.56 | 2.79 | 0.48 |
| EPS in Rs | 0.29 | 0.29 | 0.74 | 0.76 | 0.43 | 0.34 | 0.44 | 0.34 | 1.71 | 0.3 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 |
| Reserves | -3.58 | -3.11 | -2.62 | -1.39 | -0.14 | 0.56 | 1.03 | 1.93 | 2.51 | 5.29 |
| Borrowings | 1.43 | 1.56 | 1.64 | 1.19 | 0.43 | 0.46 | 0.52 | 0.44 | 0.47 | 3.02 |
| Other Liabilities | 7.72 | 9.44 | 8.93 | 26.3 | 16.68 | 1.44 | 13.58 | 28.44 | 31.7 | 18.26 |
| Total Liabilities | 21.84 | 24.16 | 24.22 | 42.37 | 33.24 | 18.73 | 31.4 | 47.08 | 50.95 | 42.84 |
| Fixed Assets | 9.16 | 9.25 | 10.29 | 10.09 | 9.78 | 9.42 | 9 | 8.62 | 8.34 | 6.94 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12.68 | 14.91 | 13.93 | 32.28 | 23.46 | 9.31 | 22.4 | 38.46 | 42.61 | 35.9 |
| Total Assets | 21.84 | 24.16 | 24.22 | 42.37 | 33.24 | 18.73 | 31.4 | 47.08 | 50.95 | 42.84 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.71 | 0.46 | 1.26 | 0.89 | 1.11 | -0.22 | -0.11 | 2.39 | -1.92 | -0.6 |
| Cash from Investing Activity | -0.48 | -0.38 | -1.41 | -0.21 | -0.1 | -0.07 | -0.01 | -0.02 | -0.1 | 1.14 |
| Cash from Financing Activity | -0.11 | -0.02 | -0.08 | -0.57 | -0.83 | -0.01 | 0.02 | -0.12 | 0 | 2.54 |
| Net Cash Flow | 0.13 | 0.06 | -0.24 | 0.12 | 0.18 | -0.3 | -0.11 | 2.25 | -2.03 | 3.07 |
| Free Cash Flow | 0.23 | 0.08 | -0.15 | 0.68 | 1.01 | -0.29 | -0.12 | 2.37 | -2.02 | 0.54 |
| CFO/OP | 35 | 103 | 134 | 63 | 112 | 8 | 10 | 314 | -205 | 9 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 311 | 383.31 | 189.84 | 365.25 | 175.81 | 116.94 | 249.08 | 301.1 | 418.77 | 354.59 |
| Inventory Days | 7.29 | 38.11 | 21.73 | 24.37 | 48.85 | 24.2 | 16.11 | 24.81 | 39.52 | 56.24 |
| Days Payable | 304.52 | 341.46 | 156.66 | 373.8 | 178.39 | 11.25 | 168.39 | 268.08 | 366.66 | 239.87 |
| Cash Conversion Cycle | 13.76 | 79.95 | 54.9 | 15.82 | 46.27 | 129.88 | 96.8 | 57.83 | 91.63 | 170.96 |
| Working Capital Days | 87.65 | 104.83 | 50.81 | 55.69 | 64.12 | 125.25 | 104.25 | 69.37 | 114.09 | 152.17 |
| ROCE % | 18.72 | 5.06 | 5 | 10.08 | 12.2 | 6.2 | 4.73 | 4.94 | 4.12 | 2.97 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.79% | 46.79% | 46.79% | 46.79% |
| FIIs | 0% | 0% | 0.03% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 37.97% | 37.67% | 38.03% | 37.27% | 38.02% | 38.18% | 38.31% | 38.18% | 38.23% | 38.27% | 38.4% | 38.63% |
| Others | 15.13% | 15.43% | 15.04% | 15.83% | 15.08% | 14.92% | 14.79% | 14.92% | 14.89% | 14.86% | 14.73% | 14.49% |
| No. of Shareholders | 26123 | 25864 | 26581 | 25480 | 26422 | 26114 | 25914 | 25685 | 25196 | 24825 | 25356 | 24999 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 7 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 32.7 | Buy |
| EMA (10) | 33.11 | Buy |
| SMA (20) | 32.26 | Buy |
| EMA (20) | 32.7 | Buy |
| SMA (50) | 32.68 | Buy |
| EMA (50) | 32.81 | Buy |
| SMA (100) | 33.5 | Buy |
| EMA (100) | 33.21 | Buy |
| SMA (200) | 33.33 | Buy |
| EMA (200) | 34.77 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 58.9 | Neutral |
| MACD (12,26,9) | 0.31 | Buy |
| Stochastic (14,3,3) | 55.37 | Neutral |
| ADX (14) | 18.26 | Neutral |
| Williams %R (14) | -50.31 | Neutral |
| ATR (14) | 2.03 | High Volatility |
| ROC (12) | 5.47 | Buy |
| Stoch RSI (14) | 53.53 | Neutral |
| UO (7,14,28) | 48.76 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d95e1b82-03c5-44d0-a815-0432aa8fc5ff.pdf) |
| 2026-08-26 | [Submission Of Notice Of Convening 41St AGM Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48896f35-63ca-45cd-ad81-a8b870d151ca.pdf) |
| 2026-08-26 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9802443d-fab1-4977-9912-3741c737f2df.pdf) |
| 2026-08-26 | [Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7268d1ed-91ad-41b4-af26-1626275652ab.pdf) |
| 2026-08-26 | [Information Regarding E-Voting For 41St Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4f6924-b928-43a8-b072-2758a5122ac6.pdf) |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=315ea3c4-69de-4c6e-8e5b-23a9fe5d45a3.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=598b5907-b07f-487e-9e49-0b9722cabfdb.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc4d6f0e-cde5-4cce-9193-be04142aa954.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d99d4bd-3d28-46d2-b0c2-d3315e64ef86.pdf) |
| 2026-08-01 | [Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 02/2026-27) Of The Company Scheduled To Be Held On Tuesday 11Th August 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b2033ee-d42b-4c35-b311-3ad1d2fdc86e.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Un-Audited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=664a6cb1-88d7-4a71-a5b6-9ce83de0c006.pdf) |
| 2026-05-30 | [Audited Financial Result For The Financial Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cd46eca-081a-4080-8de4-68b5bea35286.pdf) |
| 2026-02-13 | [Un-Audited Financial Results Of The Company For The Quarter And Nine Month Ended On 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e661c3a5-fbe0-41c6-836e-ef5f7da7590b.pdf) |
| 2025-11-13 | [To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8064f5b-d82a-4a8b-802b-f158d5cf19f4.pdf) |
| 2025-08-12 | [Un-Audited Financial Results For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fddc35e9-0f9d-4501-a764-1ab2c5aff860.pdf) |
| 2025-05-30 | [Audited Financial Result For The Financial Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1cddcdc-687e-4188-a72a-e3c7f83feaa3.pdf) |
| 2025-02-11 | [Un Audited Financial Result For Quarted Dec 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee82a8f8-fe8d-40f0-bc7d-12a02d04e8d2.pdf) |
| 2024-11-14 | [OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024 ALONGWITH FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30 SEPTEMBER 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9c05a38-c767-42c8-a981-e638558f7204.pdf) |
| 2024-08-13 | [Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June, 2024 Along With Limited Review Report Thereon](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1583fef3-4b9d-4be0-9d3f-d3a3064125d5.pdf) |
| 2024-05-30 | [Audited Results For Quarter And Year Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7656dcca-23d1-4fbf-a17c-b14ad6105854.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 5 May - Company asks physical shareholders to furnish PAN, KYC, bank details and nomination under SEBI rules. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015-Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN, KYC Details, Bank Account Details, Nomination And Other Details. 5 May - Company asks physical shareholders to furnish PAN, KYC, bank details and nomination under SEBI rules.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ccab1f10-df29-453b-860b-13a13df5d0a1.pdf) |
| 4 Feb - Publication of Unaudited (Standalone & Consolidated) Financial Results for the quarter ended 31st December, 2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Feb - Publication of Unaudited (Standalone & Consolidated) Financial Results for the quarter ended 31st December, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/07541515-c7c1-466c-b6a0-74f7630a12fc.pdf) |
| 3 Feb - Biofil confirms no material event causing share-price movement; clarification sent to BSE on 03-Feb-2026. | [Clarification On Price Movement 3 Feb - Biofil confirms no material event causing share-price movement; clarification sent to BSE on 03-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/17698270-77aa-4649-9a37-81c6487ac118.pdf) |
| 3 Apr - Submission of Publication in Newspaper pursuant to SEBI circular for Special Window for Transfer and Dematerialisation of Physcial Securities. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Apr - Submission of Publication in Newspaper pursuant to SEBI circular for Special Window for Transfer and Dematerialisation of Physcial Securities.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d46ed156-3a99-4a0f-9316-b77e73794499.pdf) |
| 24 Mar - Trading window closed from Apr 1, 2026 until 48 hours after audited results for FY/Q4 ended Mar 31, 2026. | [Closure of Trading Window 24 Mar - Trading window closed from Apr 1, 2026 until 48 hours after audited results for FY/Q4 ended Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/54dcc488-e282-4f1e-8e38-be22251c6ce6.pdf) |
| 2 Feb - Approved Q3 results; London subsidiary incorporated; KMP appointed; audit flagged tax demands ~Rs44.15cr and receivables Rs70.59cr. | [Board Meeting Outcome for Outcome Of The Meeting Of Board Of Urja Global Limited 2 Feb - Approved Q3 results; London subsidiary incorporated; KMP appointed; audit flagged tax demands ~Rs44.15cr and receivables Rs70.59cr.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b599141-ae39-4d58-b0fc-d06a9725fe11.pdf) |
| 2 Apr - Company informs shareholders of SEBI special window for physical securities transfer and dematerialisation from Feb 5, 2026 to Feb 4, 2027. | [Intimation Regarding SEBI Circular Dated January 30, 2026 - Ease Of Doing Investment - Special Window For Transfer And Dematerialisation Of Physical Securities 2 Apr - Company informs shareholders of SEBI special window for physical securities transfer and dematerialisation from Feb 5, 2026 to Feb 4, 2027.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69acac2a-02a3-460d-8e0a-4493197c79bc.pdf) |
| 19 Jan - Board meeting Feb 2, 2026 to approve unaudited Q3/nine-month results (31 Dec 2025); trading window closed from Jan 1, 2026. | [Board Meeting Intimation for Intimation Of Board Meeting For The Quarter And Nine Months Ended On 31St December, 2025 19 Jan - Board meeting Feb 2, 2026 to approve unaudited Q3/nine-month results (31 Dec 2025); trading window closed from Jan 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4c122419-e6c5-4414-9b43-0f2e62525aab.pdf) |
| 14 Feb - Submission of Publication of Un-audited Financial Results for the quarter and nine months ended on 31st December 2025 in the newspaper pursuant to Regulation 47 … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb - Submission of Publication of Un-audited Financial Results for the quarter and nine months ended on 31st December 2025 in the newspaper pursuant to Regulation 47 …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/096d9d6f-2905-4c6b-86ab-9e72184ed5a8.pdf) |
| 13 Feb - Board approved Q3/9M results ended 31 Dec 2025; Q3 profit Rs7.92L, 9M profit Rs257.37L. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 13Th February, 2026 13 Feb - Board approved Q3/9M results ended 31 Dec 2025; Q3 profit Rs7.92L, 9M profit Rs257.37L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b34a9665-c3b6-43a7-a00a-e1c03e9f1257.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6b785185-5106-4c14-b55f-365ae1ab49b1.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7762b4a-fe64-4914-a871-ca91ab68ad44.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/98174f63-b674-457e-a61b-471346b01549.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/170d3826-e664-47e0-a53b-d421f0d37781.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/419b34bc-dedf-4d03-baa3-6b3f39c97cbd.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93696440-7906-4c14-85cb-006d94b2f37a.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524396/75981524396.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/526987/77293526987.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524396/70387524396.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/526987/69257526987_05_08_21.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:22:21.762Z.